SOAP Note: 15-Year-Old Male with Ingrown Toenail and Cellulitis
SUBJECTIVE
- Chief Complaint: Ingrown toenail, left great toe
- History of Present Illness: 15-year-old male presents with ingrown toenail to left hallux with associated swelling, erythema, and cellulitis. Patient reports difficulty wearing shoes due to pain and inflammation. Started oral antibiotics one week ago (specify antibiotic name and dose if available).
- Past Medical History: None documented
- Medications: Oral antibiotic (started 1 week ago - specify agent)
- Allergies: NKDA (document if known)
OBJECTIVE
- Vital Signs: (Document temperature, HR, BP, RR if obtained)
- Physical Examination:
- Left great toe: Erythema and edema of lateral nail fold
- Cellulitis present with warmth and tenderness
- No purulent drainage noted (or document if present)
- No systemic signs of infection (fever, tachycardia)
- Neurovascular status intact distally
ASSESSMENT
- Ingrown toenail (onychocryptosis), left great toe, stage II-III - complicated by cellulitis
- Cellulitis, left great toe - responding to oral antibiotics
Clinical Reasoning: This patient has a moderate-to-severe ingrown toenail with secondary cellulitis. Continue oral β-lactam antibiotic therapy (cephalexin, amoxicillin, or penicillin) as cellulitis in this setting is typically caused by streptococci or methicillin-sensitive Staphylococcus aureus 1. The presence of cellulitis does not contraindicate definitive surgical management; partial nail matrix excision is the appropriate treatment for stage II-III ingrown toenails 2, 3.
PLAN
Procedure Performed Today:
Partial nail matrix excision, left great toe
- Local anesthesia achieved with lidocaine 1% without epinephrine (document volume used; maximum dose 4.5 mg/kg or 300 mg total in adolescents) 4
- Digital block performed without complications
- Partial avulsion of lateral nail edge performed
- Chemical matricectomy with phenol application (if performed - phenol superior to surgical excision alone for preventing recurrence) 5, 6
- Hemostasis achieved
- Sterile dressing applied
Post-Procedure Management:
Antibiotic Therapy:
- Continue current oral β-lactam antibiotic for total 5-10 days (if clinical improvement evident by day 5, a 5-day course is sufficient for uncomplicated cellulitis) 1
- β-lactam monotherapy (cephalexin, amoxicillin, or penicillin) is appropriate; MRSA coverage not indicated in absence of purulent drainage 1
Wound Care:
- Keep dressing clean and dry for 24-48 hours
- Begin warm water soaks after 48 hours, twice daily
- Apply topical antibiotic ointment and redress daily
- Elevate foot when possible to reduce edema 1
Pain Management:
- Ibuprofen 400-600 mg every 6-8 hours as needed
- Acetaminophen 500-1000 mg every 6 hours as needed (alternate with ibuprofen if necessary)
Activity:
- Wear open-toed shoes or loose-fitting footwear until healing complete
- Avoid prolonged standing/walking for 48-72 hours
- May return to normal activity as tolerated after 3-5 days
Follow-Up:
Patient Education:
- Proper nail care: trim nails straight across, not too short
- Wear properly fitted shoes
- Signs/symptoms requiring immediate return: fever, increased redness spreading up foot, purulent drainage, severe pain
BILLING CODES
CPT Code:
11750 - Excision of nail and nail matrix, partial or complete (e.g., ingrown or deformed nail), for permanent removal
ICD-10 Codes:
- L60.0 - Ingrowing nail (primary diagnosis)
- L03.046 - Cellulitis of left toe
- Z98.890 - Other specified postprocedural states (if documenting post-procedure status on subsequent visit)
Clinical Pearls: Phenol matricectomy after partial nail avulsion has lower recurrence rates (3-13%) compared to surgical excision alone 5, 6. Local antibiotics do not reduce infection risk or recurrence 6. The cellulitis should continue to improve on oral β-lactam therapy; escalation to MRSA coverage is unnecessary unless purulent drainage develops 1.